Leftwich Scott bought CLDI
December 21, 2023 · Form 4 insider transaction
Leftwich Scott bought 8,958 shares of Calidi Biotherapeutics, Inc. at $1.80 per share, a transaction worth $16.1K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 14 days after the transaction.
Footnotes
Represents a grant of restricted stock units ("RSUs") subject to the conditions of the Restricted Stock Unit Award Agreement pursuant to the Issuer's 2023 Plan. Each RSU represents a right to receive one share of the Company's common stock upon vesting. The number of RSUs to be issued will equal to the amount due to the director for Board fees divided by the closing price for a share of the Issuer's common stock of $1.80. The RSUs were granted in a transaction exempt under Rule 16b-3 to the Reporting Person. The shares of common stock underlying the RSUs immediately vested on the Grant Date.